HighlightsExploration Permit Applications filed for:Phase 2 Diamond Drilling at the Pt. Leamington VMS Deposit targeting deposit resource upgrade / expansion of the emerging Kraken...
HighlightsExploration Permit Applications filed for:Phase 2 Diamond Drilling at the Pt. Leamington VMS Deposit targeting deposit resource upgrade / expansion of the emerging Kraken...
Industry-academia collaboration brings hands-on AI learning and real-world technology exposure to students across three campusesCOIMBATORE, India, June 4, 2026 /PRNewswire/ -- Orion Innovation ("Orion"), a...
Identity-First Reachability™ eliminates the attack surface that AI agents, MCP servers, and LLMs create — addressing the #1 breach vector in enterprise security todayCHARLOTTE,...
MEQUON, Wis., June 2, 2026 /PRNewswire/ -- Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors...
EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on August 12, 2025, the compensation committee of the Company’s board of directors granted three new non-executive employees 58,900 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.
PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...
GUANGZHOU, China, Aug. 14, 2025 /PRNewswire/ -- AI is reshaping the business world at an unprecedented pace. From early theoretical exploration to the explosive...
PALO ALTO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- With fast emerging requirements for AI everywhere - Enterprises face new challenges in modernizing their core infrastructure, systems, and applications to adopt an AI-centric future. With an ever-expanding multi-cloud data estate, enterprises are grappling with brittle data pipelines, ETL based batch lag, lack of automated agents, and siloed data architectures that are complex to integrate.
NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO), announces that it signed a binding agreement to initiate manufacturing and development...